Dual PI therapy emerges as most viable combination.
D002985:Clinical Protocols / Q000592:standards*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019438:Ritonavir / Q000627:therapeutic use*; D019258:Saquinavir / Q000627:therapeutic use*; D019562:Viral Load
D017320:HIV Protease Inhibitors; D019258:Saquinavir; D019438:Ritonavir